cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Alvotech Sa
1 own
Current Price
$13.48
$-0.03
(-0.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,119.15M
52-Week High
52-Week High
18.00000
52-Week Low
52-Week Low
6.70000
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization3,119.15M
icon52-Week High18.00000
icon52-Week Low6.70000
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Alvotech Sa do?
N/A
Read More
News & Events about Alvotech Sa.
Globe Newswire
11 months ago
NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ascendis Pharma A/S...
Globe Newswire
12 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zai Lab Limited (Zai Lab Limited), Hayward Holdings, Inc. (NYSE: HAYW), Ascendis Pharma A/S (NASDAQ: ASND), and Alvotech SA (NASDAQ...
Globe Newswire
1 year ago
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against C3.ai, Inc. (NYSE: AI), Ascendis Pharma A/S (NASDAQ: ASND), Alvotech SA (NASDAQ: ALVO), and Shift4 Payments, Inc. (NYSE: FOUR). Our ...
Globe Newswire
1 year ago
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company ...
Globe Newswire
1 year ago
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and ...
Frequently Asked Questions
Frequently Asked Questions
What is Alvotech Sa share price today?
plus_minus_icon
Can Indians buy Alvotech Sa shares?
plus_minus_icon
How can I buy Alvotech Sa shares from India?
plus_minus_icon
Can Fractional shares of Alvotech Sa be purchased?
plus_minus_icon
What are the documents required to start investing in Alvotech Sa stocks?
plus_minus_icon
What is today’s traded volume of Alvotech Sa?
plus_minus_icon
What is today’s market capitalisation of Alvotech Sa?
plus_minus_icon
What is the 52-Week High and Low Range of Alvotech Sa?
plus_minus_icon
What percentage is Alvotech Sa down from its 52-Week High?
plus_minus_icon
What percentage is Alvotech Sa up from its 52-Week Low?
plus_minus_icon
Current Price
$13.48
$-0.03
(-0.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00